The global market for Microfluidics-based 3D Cell Culture was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Three-dimensional cell culture technology refers to the co-cultivation of carriers with different materials with three-dimensional structures and various types of cells in vitro, so that cells can migrate and grow in the three-dimensional spatial structure of the carrier to form a three-dimensional cell-carrier complex.
3D cell culture refers to the co-cultivation of animal cells with scaffold materials with a three-dimensional structure, so that cells can grow, proliferate and migrate in three-dimensional space, forming a three-dimensional cell-cell or cell-carrier complex, so as to better simulate The environment in which cells grow in the body. At present, it is mainly divided into three-dimensional culture techniques with scaffolds and without scaffolds. Among them, the materials attached to scaffolds mainly include collagen and hydrogel, etc., which are cheap and easy to operate; those that do not attach to scaffolds are mainly cultured by physical methods, mainly including microcarriers. , magnetic levitation, hanging drop plate, etc., such operations are complex and costly. The term Three-dimensional cell culture (3D cell culture) has become a hot topic in the field of biological sciences. In recent years, the number of published articles or comments on "3D cell culture" has increased rapidly, and organoid technology derived from 3D cell culture has also become a sharp weapon for researchers. In 2017, "Nature Methods", a sub-journal of "Nature", evaluated organoids as the annual technology in the field of life; in 2019, Organoids appeared on the cover of "Science" magazine, and it was a special issue of organoids. Quietly, organoid technology appeared in major top journals. In 2021, the "14th Five-Year Plan" key research and development plan will list the research of related tumor organoids as the first batch of key special tasks.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microfluidics-based 3D Cell Culture, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microfluidics-based 3D Cell Culture.
The Microfluidics-based 3D Cell Culture market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microfluidics-based 3D Cell Culture market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microfluidics-based 3D Cell Culture manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Thermo Fisher Scientific
Corning
Merck
Lonza
Reprocell
3D Biotek
Emulate
Global Cell Solutions
Hamilton
Insphero
Kuraray
Mimetas
Nano3D Biosciences
Synthecon
Qgel
Segment by Type
10-50渭尘
50-100渭尘
Segment by Application
Cancer Research
Stem Cell Research
Drug Discovery
Regenerative Medicine
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microfluidics-based 3D Cell Culture manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microfluidics-based 3D Cell Culture in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Microfluidics-based 3D Cell Culture Market Overview
1.1 Product Definition
1.2 Microfluidics-based 3D Cell Culture by Type
1.2.1 Global Microfluidics-based 3D Cell Culture Market Value Comparison by Type (2024 VS 2031)
1.2.2 10-50渭尘
1.2.3 50-100渭尘
1.3 Microfluidics-based 3D Cell Culture by Application
1.3.1 Global Microfluidics-based 3D Cell Culture Market Value by Application (2024 VS 2031)
1.3.2 Cancer Research
1.3.3 Stem Cell Research
1.3.4 Drug Discovery
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Global Microfluidics-based 3D Cell Culture Market Size Estimates and Forecasts
1.4.1 Global Microfluidics-based 3D Cell Culture Revenue 2020-2031
1.4.2 Global Microfluidics-based 3D Cell Culture Sales 2020-2031
1.4.3 Global Microfluidics-based 3D Cell Culture Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microfluidics-based 3D Cell Culture Market Competition by Manufacturers
2.1 Global Microfluidics-based 3D Cell Culture Sales Market Share by Manufacturers (2020-2025)
2.2 Global Microfluidics-based 3D Cell Culture Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Microfluidics-based 3D Cell Culture Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microfluidics-based 3D Cell Culture, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microfluidics-based 3D Cell Culture, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microfluidics-based 3D Cell Culture, Product Type & Application
2.7 Global Key Manufacturers of Microfluidics-based 3D Cell Culture, Date of Enter into This Industry
2.8 Global Microfluidics-based 3D Cell Culture Market Competitive Situation and Trends
2.8.1 Global Microfluidics-based 3D Cell Culture Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Microfluidics-based 3D Cell Culture Players Market Share by Revenue
2.8.3 Global Microfluidics-based 3D Cell Culture Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microfluidics-based 3D Cell Culture Market Scenario by Region
3.1 Global Microfluidics-based 3D Cell Culture Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microfluidics-based 3D Cell Culture Sales by Region: 2020-2031
3.2.1 Global Microfluidics-based 3D Cell Culture Sales by Region: 2020-2025
3.2.2 Global Microfluidics-based 3D Cell Culture Sales by Region: 2026-2031
3.3 Global Microfluidics-based 3D Cell Culture Revenue by Region: 2020-2031
3.3.1 Global Microfluidics-based 3D Cell Culture Revenue by Region: 2020-2025
3.3.2 Global Microfluidics-based 3D Cell Culture Revenue by Region: 2026-2031
3.4 North America Microfluidics-based 3D Cell Culture Market Facts & Figures by Country
3.4.1 North America Microfluidics-based 3D Cell Culture Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microfluidics-based 3D Cell Culture Sales by Country (2020-2031)
3.4.3 North America Microfluidics-based 3D Cell Culture Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microfluidics-based 3D Cell Culture Market Facts & Figures by Country
3.5.1 Europe Microfluidics-based 3D Cell Culture Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microfluidics-based 3D Cell Culture Sales by Country (2020-2031)
3.5.3 Europe Microfluidics-based 3D Cell Culture Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microfluidics-based 3D Cell Culture Market Facts & Figures by Region
3.6.1 Asia Pacific Microfluidics-based 3D Cell Culture Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microfluidics-based 3D Cell Culture Sales by Region (2020-2031)
3.6.3 Asia Pacific Microfluidics-based 3D Cell Culture Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microfluidics-based 3D Cell Culture Market Facts & Figures by Country
3.7.1 Latin America Microfluidics-based 3D Cell Culture Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microfluidics-based 3D Cell Culture Sales by Country (2020-2031)
3.7.3 Latin America Microfluidics-based 3D Cell Culture Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microfluidics-based 3D Cell Culture Market Facts & Figures by Country
3.8.1 Middle East and Africa Microfluidics-based 3D Cell Culture Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microfluidics-based 3D Cell Culture Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microfluidics-based 3D Cell Culture Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microfluidics-based 3D Cell Culture Sales by Type (2020-2031)
4.1.1 Global Microfluidics-based 3D Cell Culture Sales by Type (2020-2025)
4.1.2 Global Microfluidics-based 3D Cell Culture Sales by Type (2026-2031)
4.1.3 Global Microfluidics-based 3D Cell Culture Sales Market Share by Type (2020-2031)
4.2 Global Microfluidics-based 3D Cell Culture Revenue by Type (2020-2031)
4.2.1 Global Microfluidics-based 3D Cell Culture Revenue by Type (2020-2025)
4.2.2 Global Microfluidics-based 3D Cell Culture Revenue by Type (2026-2031)
4.2.3 Global Microfluidics-based 3D Cell Culture Revenue Market Share by Type (2020-2031)
4.3 Global Microfluidics-based 3D Cell Culture Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microfluidics-based 3D Cell Culture Sales by Application (2020-2031)
5.1.1 Global Microfluidics-based 3D Cell Culture Sales by Application (2020-2025)
5.1.2 Global Microfluidics-based 3D Cell Culture Sales by Application (2026-2031)
5.1.3 Global Microfluidics-based 3D Cell Culture Sales Market Share by Application (2020-2031)
5.2 Global Microfluidics-based 3D Cell Culture Revenue by Application (2020-2031)
5.2.1 Global Microfluidics-based 3D Cell Culture Revenue by Application (2020-2025)
5.2.2 Global Microfluidics-based 3D Cell Culture Revenue by Application (2026-2031)
5.2.3 Global Microfluidics-based 3D Cell Culture Revenue Market Share by Application (2020-2031)
5.3 Global Microfluidics-based 3D Cell Culture Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Microfluidics-based 3D Cell Culture Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Corning
6.2.1 Corning Company Information
6.2.2 Corning Description and Business Overview
6.2.3 Corning Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Corning Microfluidics-based 3D Cell Culture Product Portfolio
6.2.5 Corning Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Microfluidics-based 3D Cell Culture Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Lonza
6.4.1 Lonza Company Information
6.4.2 Lonza Description and Business Overview
6.4.3 Lonza Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lonza Microfluidics-based 3D Cell Culture Product Portfolio
6.4.5 Lonza Recent Developments/Updates
6.5 Reprocell
6.5.1 Reprocell Company Information
6.5.2 Reprocell Description and Business Overview
6.5.3 Reprocell Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Reprocell Microfluidics-based 3D Cell Culture Product Portfolio
6.5.5 Reprocell Recent Developments/Updates
6.6 3D Biotek
6.6.1 3D Biotek Company Information
6.6.2 3D Biotek Description and Business Overview
6.6.3 3D Biotek Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.6.4 3D Biotek Microfluidics-based 3D Cell Culture Product Portfolio
6.6.5 3D Biotek Recent Developments/Updates
6.7 Emulate
6.7.1 Emulate Company Information
6.7.2 Emulate Description and Business Overview
6.7.3 Emulate Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Emulate Microfluidics-based 3D Cell Culture Product Portfolio
6.7.5 Emulate Recent Developments/Updates
6.8 Global Cell Solutions
6.8.1 Global Cell Solutions Company Information
6.8.2 Global Cell Solutions Description and Business Overview
6.8.3 Global Cell Solutions Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Global Cell Solutions Microfluidics-based 3D Cell Culture Product Portfolio
6.8.5 Global Cell Solutions Recent Developments/Updates
6.9 Hamilton
6.9.1 Hamilton Company Information
6.9.2 Hamilton Description and Business Overview
6.9.3 Hamilton Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hamilton Microfluidics-based 3D Cell Culture Product Portfolio
6.9.5 Hamilton Recent Developments/Updates
6.10 Insphero
6.10.1 Insphero Company Information
6.10.2 Insphero Description and Business Overview
6.10.3 Insphero Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Insphero Microfluidics-based 3D Cell Culture Product Portfolio
6.10.5 Insphero Recent Developments/Updates
6.11 Kuraray
6.11.1 Kuraray Company Information
6.11.2 Kuraray Description and Business Overview
6.11.3 Kuraray Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Kuraray Microfluidics-based 3D Cell Culture Product Portfolio
6.11.5 Kuraray Recent Developments/Updates
6.12 Mimetas
6.12.1 Mimetas Company Information
6.12.2 Mimetas Description and Business Overview
6.12.3 Mimetas Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mimetas Microfluidics-based 3D Cell Culture Product Portfolio
6.12.5 Mimetas Recent Developments/Updates
6.13 Nano3D Biosciences
6.13.1 Nano3D Biosciences Company Information
6.13.2 Nano3D Biosciences Description and Business Overview
6.13.3 Nano3D Biosciences Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nano3D Biosciences Microfluidics-based 3D Cell Culture Product Portfolio
6.13.5 Nano3D Biosciences Recent Developments/Updates
6.14 Synthecon
6.14.1 Synthecon Company Information
6.14.2 Synthecon Description and Business Overview
6.14.3 Synthecon Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Synthecon Microfluidics-based 3D Cell Culture Product Portfolio
6.14.5 Synthecon Recent Developments/Updates
6.15 Qgel
6.15.1 Qgel Company Information
6.15.2 Qgel Description and Business Overview
6.15.3 Qgel Microfluidics-based 3D Cell Culture Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Qgel Microfluidics-based 3D Cell Culture Product Portfolio
6.15.5 Qgel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microfluidics-based 3D Cell Culture Industry Chain Analysis
7.2 Microfluidics-based 3D Cell Culture Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microfluidics-based 3D Cell Culture Production Mode & Process Analysis
7.4 Microfluidics-based 3D Cell Culture Sales and Marketing
7.4.1 Microfluidics-based 3D Cell Culture Sales Channels
7.4.2 Microfluidics-based 3D Cell Culture Distributors
7.5 Microfluidics-based 3D Cell Culture Customer Analysis
8 Microfluidics-based 3D Cell Culture Market Dynamics
8.1 Microfluidics-based 3D Cell Culture Industry Trends
8.2 Microfluidics-based 3D Cell Culture Market Drivers
8.3 Microfluidics-based 3D Cell Culture Market Challenges
8.4 Microfluidics-based 3D Cell Culture Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Thermo Fisher Scientific
Corning
Merck
Lonza
Reprocell
3D Biotek
Emulate
Global Cell Solutions
Hamilton
Insphero
Kuraray
Mimetas
Nano3D Biosciences
Synthecon
Qgel
听
听
*If Applicable.
